Junjun Zhou

1.0k total citations
35 papers, 842 citations indexed

About

Junjun Zhou is a scholar working on Physiology, Epidemiology and Pharmacology. According to data from OpenAlex, Junjun Zhou has authored 35 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Junjun Zhou's work include Biochemical effects in animals (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Junjun Zhou is often cited by papers focused on Biochemical effects in animals (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Junjun Zhou collaborates with scholars based in China, United States and Malaysia. Junjun Zhou's co-authors include Jihong Yao, Yan Zhao, Xiaofeng Tian, Zhecheng Wang, Cheng‐Peng Sun, Zhenlong Yu, Xiaochi Ma, Xiaokui Huo, Ruimin Sun and Dongyan Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Brain Research.

In The Last Decade

Junjun Zhou

34 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjun Zhou China 18 367 222 126 105 83 35 842
Ahmed S. Ibrahim Egypt 21 487 1.3× 83 0.4× 51 0.4× 77 0.7× 113 1.4× 64 1.5k
Jingwei Tian China 22 497 1.4× 96 0.4× 102 0.8× 61 0.6× 19 0.2× 52 1.1k
Marawan A. Elbaset Egypt 18 220 0.6× 142 0.6× 106 0.8× 42 0.4× 38 0.5× 70 803
Xiaowei Huang China 15 511 1.4× 128 0.6× 48 0.4× 301 2.9× 78 0.9× 63 1.1k
Xin Jia China 17 492 1.3× 269 1.2× 74 0.6× 91 0.9× 30 0.4× 40 952
Kefeng Zhang China 15 328 0.9× 116 0.5× 99 0.8× 136 1.3× 16 0.2× 52 806
Luigi Sapio Italy 20 565 1.5× 125 0.6× 32 0.3× 150 1.4× 15 0.2× 39 1.2k

Countries citing papers authored by Junjun Zhou

Since Specialization
Citations

This map shows the geographic impact of Junjun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjun Zhou more than expected).

Fields of papers citing papers by Junjun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjun Zhou. The network helps show where Junjun Zhou may publish in the future.

Co-authorship network of co-authors of Junjun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Junjun Zhou. A scholar is included among the top collaborators of Junjun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjun Zhou. Junjun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ying, Jianping Jia, Li Wang, et al.. (2025). BAP31 represses endoplasmic reticulum stress-mediated apoptosis and alleviates neurodegeneration in Parkinson’s disease. Cell Death and Disease. 16(1). 672–672. 1 indexed citations
2.
3.
Tang, Fan, Zhecheng Wang, Junjun Zhou, & Jihong Yao. (2023). Salvianolic Acid A Protects against Acetaminophen-Induced Hepatotoxicity via Regulation of the miR-485-3p/SIRT1 Pathway. Antioxidants. 12(4). 870–870. 7 indexed citations
4.
Sun, Cheng‐Peng, Xinyue Zhang, Junjun Zhou, et al.. (2021). Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway. Food and Chemical Toxicology. 156. 112516–112516. 32 indexed citations
5.
Wang, Zhecheng, Yan Zhao, Ruimin Sun, et al.. (2020). circ-CBFB upregulates p66Shc to perturb mitochondrial dynamics in APAP-induced liver injury. Cell Death and Disease. 11(11). 953–953. 24 indexed citations
6.
Zhou, Junjun, Yan Zhao, Zhenlu Li, et al.. (2020). miR-103a-3p regulates mitophagy in Parkinson’s disease through Parkin/Ambra1 signaling. Pharmacological Research. 160. 105197–105197. 62 indexed citations
7.
Zhao, Yan, Zhecheng Wang, Junjun Zhou, et al.. (2020). LncRNA Mical2/miR-203a-3p sponge participates in epithelial-mesenchymal transition by targeting p66Shc in liver fibrosis. Toxicology and Applied Pharmacology. 403. 115125–115125. 11 indexed citations
8.
Sun, Ruimin, Xiaohui Kang, Yan Zhao, et al.. (2020). Sirtuin 3‐mediated deacetylation of acyl‐CoA synthetase family member 3 by protocatechuic acid attenuates non‐alcoholic fatty liver disease. British Journal of Pharmacology. 177(18). 4166–4180. 47 indexed citations
9.
Wang, Zhecheng, Yan Zhao, Huanyu Zhao, et al.. (2020). Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression. Molecular Therapy — Nucleic Acids. 21. 751–763. 12 indexed citations
10.
Fu, Rong, Junjun Zhou, Ruiwen Wang, et al.. (2019). Protocatechuic Acid-Mediated miR-219a-5p Activation Inhibits the p66shc Oxidant Pathway to Alleviate Alcoholic Liver Injury. Oxidative Medicine and Cellular Longevity. 2019. 1–15. 28 indexed citations
11.
Sun, Cheng‐Peng, et al.. (2019). Flavonoids as human carboxylesterase 2 inhibitors: Inhibition potentials and molecular docking simulations. International Journal of Biological Macromolecules. 131. 201–208. 20 indexed citations
12.
Zhou, Junjun, et al.. (2018). Effect of a new inhibitor of factor Xa zifaxaban, on thrombosis in the inferior vena cava in rabbits. Journal of Thrombosis and Thrombolysis. 47(1). 80–86. 2 indexed citations
13.
Zhang, Shuai, Zhecheng Wang, Jie Zhu, et al.. (2018). Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats. Frontiers in Pharmacology. 8. 976–976. 33 indexed citations
14.
Shi, Xue, Yan Zhao, Zhecheng Wang, et al.. (2018). Salvianolic acid A alleviates chronic ethanol-induced liver injury via promotion of β-catenin nuclear accumulation by restoring SIRT1 in rats. Toxicology and Applied Pharmacology. 350. 21–31. 13 indexed citations
15.
Lan, Yu‐Long, Junjun Zhou, Jing Liu, et al.. (2018). Uncaria rhynchophylla Ameliorates Parkinson’s Disease by Inhibiting HSP90 Expression: Insights from Quantitative Proteomics. Cellular Physiology and Biochemistry. 47(4). 1453–1464. 44 indexed citations
16.
Zhu, Jie, Ruiwen Wang, Ting Xu, et al.. (2018). Salvianolic Acid A Attenuates Endoplasmic Reticulum Stress and Protects Against Cholestasis-Induced Liver Fibrosis via the SIRT1/HSF1 Pathway. Frontiers in Pharmacology. 9. 1277–1277. 29 indexed citations
17.
Zhao, Huanyu, Zhecheng Wang, Fan Tang, et al.. (2017). Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis. Pharmacological Research. 128. 327–337. 42 indexed citations
18.
Xu, Ting, Junjun Zhou, Jie Zhu, et al.. (2016). Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats. Metabolic Brain Disease. 32(2). 483–491. 11 indexed citations
19.
Zhou, Junjun, et al.. (2009). Oxymatrine–carbenoxolone sodium inclusion compound induces antinociception and increases the expression of GABAAα1 receptors in mice. European Journal of Pharmacology. 626(2-3). 244–249. 6 indexed citations
20.
Zhou, Junjun, et al.. (2008). [Studies on analgesic effects and sites of oxymatrine-carbenoxolone sodium complex].. PubMed. 33(7). 822–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed S. Ibrahim Breakdown of academic impact, for papers by Jingwei Tian Breakdown of academic impact, for papers by Marawan A. Elbaset Breakdown of academic impact, for papers by Xiaowei Huang Breakdown of academic impact, for papers by Xin Jia Breakdown of academic impact, for papers by Kefeng Zhang Breakdown of academic impact, for papers by Luigi Sapio
Rankless by CCL
2026